Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Martin

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
American Journal of Clinical Pathology|September 9, 1999
Biomarkers of liver regeneration allow early prediction of hepatic recovery after acute necrosisK D Horn, P Wax, S M Schneider, et al.
Leukemia|November 9, 2007
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndromeM de Lima, R E Champlin, P F Thall, et al.
Bone Marrow Transplantation|September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisG N Mannis, A C Logan, A D Leavitt, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
American Journal of Clinical Pathology|September 9, 1999
Biomarkers of liver regeneration allow early prediction of hepatic recovery after acute necrosisK D Horn, P Wax, S M Schneider, et al.
Leukemia|November 9, 2007
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndromeM de Lima, R E Champlin, P F Thall, et al.
Bone Marrow Transplantation|September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisG N Mannis, A C Logan, A D Leavitt, et al.
Pageof 6